Health benefit plans and Medicaid; require to offer coverage for biomarker testing.

Summary

The act mandates that any health benefit plan or contract entered into after July 1, 2026 must provide coverage for biomarker testing when the test is supported by medical and scientific evidence. It applies to private insurers, Medicaid, and the state‑run employee health plan, aiming to improve diagnosis and treatment monitoring. Plans must publish their policies, limit disruptions in care, and give clear reasons for any claim denial.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share